MTST Stock - MetaStat, Inc.
Unlock GoAI Insights for MTST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $23,300 | N/A | N/A | N/A | N/A |
| Gross Profit | $23,300 | N/A | N/A | N/A | N/A |
| Gross Margin | 100.0% | N/A | N/A | N/A | N/A |
| Operating Income | $-3,549,875 | $3.35M | $4.78M | $4.79M | $4.35M |
| Net Income | $-3,181,024 | $-2,941,557 | $-4,654,179 | $-7,995,474 | $-5,365,196 |
| Net Margin | -13652.5% | N/A | N/A | N/A | N/A |
| EPS | $-0.59 | $-0.99 | $-2.56 | $-4.81 | $-3.80 |
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Visit WebsiteEarnings History & Surprises
MTSTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2018 | May 29, 2018 | — | $-0.09 | — | — |
Q1 2018 | Feb 28, 2018 | — | $-0.17 | — | — |
Q1 2018 | Feb 28, 2018 | — | $-0.15 | — | — |
Q1 2018 | Jan 16, 2018 | — | $-0.21 | — | — |
Q4 2017 | Nov 30, 2017 | — | $-0.20 | — | — |
Q4 2017 | Oct 16, 2017 | — | $-0.16 | — | — |
Q3 2017 | Aug 31, 2017 | — | $-0.15 | — | — |
Q3 2017 | Jul 17, 2017 | — | $-0.06 | — | — |
Q1 2017 | Feb 28, 2017 | — | $-0.31 | — | — |
Q1 2017 | Jan 17, 2017 | — | $-1.04 | — | — |
Q4 2016 | Oct 14, 2016 | — | $-0.46 | — | — |
Q3 2016 | Jul 14, 2016 | — | $-1.08 | — | — |
Q1 2016 | Feb 29, 2016 | — | $0.30 | — | — |
Q1 2016 | Jan 14, 2016 | $-1.03 | $-0.72 | +30.1% | ✓ BEAT |
Q4 2015 | Oct 15, 2015 | $-0.90 | $-0.73 | +18.9% | ✓ BEAT |
Q2 2015 | May 31, 2015 | — | $-0.67 | — | — |
Q1 2015 | Feb 28, 2015 | — | $-0.61 | — | — |
Q4 2014 | Nov 30, 2014 | — | $-0.79 | — | — |
Q3 2014 | Aug 31, 2014 | — | $-2.36 | — | — |
Q2 2014 | May 31, 2014 | — | $-0.85 | — | — |
Latest News
Frequently Asked Questions about MTST
What is MTST's current stock price?
What is the analyst price target for MTST?
What sector is MetaStat, Inc. in?
What is MTST's market cap?
Does MTST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MTST for comparison